Hisamitsu Pharmaceutical Co's total assets for Q3 2024 were ¥334.81B, a decrease of -4.47% from the previous quarter. HTSUF total liabilities were ¥72.51B for the fiscal quarter, a -2.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.